The solution structure of the unbound IgG Fc receptor CD64 resembles its crystal structure: Implications for function.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 16 01 2023
accepted: 23 06 2023
medline: 25 9 2023
pubmed: 21 9 2023
entrez: 21 9 2023
Statut: epublish

Résumé

FcγRI (CD64) is the only high-affinity Fcγ receptor found on monocytes, macrophages, eosinophils, neutrophils and dendritic cells. It binds immunoglobulin G (IgG) antibody-antigen complexes at its Fc region to trigger key immune responses. CD64 contains three immunoglobulin-fold extracellular domains (D1, D2 and D3) and a membrane-spanning region. Despite the importance of CD64, no solution structure for this is known to date. To investigate this, we used analytical ultracentrifugation, small-angle X-ray scattering, and atomistic modelling. Analytical ultracentrifugation revealed that CD64 was monomeric with a sedimentation coefficient s020,w of 2.53 S, together with some dimer. Small-angle X-ray scattering showed that its radius of gyration RG was 3.3-3.4 nm and increased at higher concentrations to indicate low dimerization. Monte Carlo modelling implemented in the SASSIE-web package generated 279,162 physically-realistic trial CD64 structures. From these, the scattering best-fit models at the lowest measured concentrations that minimised dimers revealed that the D1, D2 and D3 domains were structurally similar to those seen in three CD64 crystal structures, but showed previously unreported flexibility between D1, D2 and D3. Despite the limitations of the scattering data, the superimposition of the CD64 solution structures onto crystal structures of the IgG Fc-CD64 complex showed that the CD64 domains do not sterically clash with the IgG Fc region, i.e. the solution structure of CD64 was sufficiently compact to allow IgG to bind to its high-affinity Fcγ receptor. This improved understanding may result in novel approaches to inhibit CD64 function, and opens the way for the solution study of the full-length CD64-IgG complex.

Identifiants

pubmed: 37733670
doi: 10.1371/journal.pone.0288351
pii: PONE-D-23-01338
pmc: PMC10513344
doi:

Substances chimiques

Receptors, IgG 0
Immunoglobulin G 0
Antigen-Antibody Complex 0
Polymers 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0288351

Informations de copyright

Copyright: © 2023 Hui et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Curr Opin Struct Biol. 2013 Oct;23(5):748-54
pubmed: 23835228
J Appl Crystallogr. 2015 May 09;48(Pt 3):953-961
pubmed: 26089768
Biophys J. 1998 Sep;75(3):1503-12
pubmed: 9726952
J Immunol. 2008 Jan 1;180(1):580-9
pubmed: 18097060
Nature. 2013 Apr 25;496(7446):477-81
pubmed: 23619693
Annu Rev Phys Chem. 2013;64:37-54
pubmed: 23216378
Immunol Rev. 2015 Nov;268(1):25-51
pubmed: 26497511
Chem Rev. 2001 Jun;101(6):1763-78
pubmed: 11709998
Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):833-8
pubmed: 25561553
Scand J Rheumatol. 2015;44(6):464-73
pubmed: 26084203
J Clin Immunol. 2016 May;36 Suppl 1:95-9
pubmed: 27039179
Eur Biophys J. 2012 Oct;41(10):789-99
pubmed: 22639100
Biophys J. 2000 Mar;78(3):1606-19
pubmed: 10692345
J Biol Chem. 2011 Nov 25;286(47):40608-13
pubmed: 21965667
J Immunol. 2011 Mar 1;186(5):2699-704
pubmed: 21325219
Arthritis Res Ther. 2010;12(3):R90
pubmed: 20478071
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Protein Expr Purif. 2012 Mar;82(1):155-61
pubmed: 22226868
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
J Comput Chem. 2004 Aug;25(11):1400-15
pubmed: 15185334
Appl Microbiol Biotechnol. 2012 May;94(4):1051-9
pubmed: 22290651
Biophys J. 2011 Aug 17;101(4):892-8
pubmed: 21843480
Acta Crystallogr D Biol Crystallogr. 2015 Nov;71(Pt 11):2354-61
pubmed: 26527150
Adv Exp Med Biol. 2017;1009:47-64
pubmed: 29218553
Methods. 2011 May;54(1):181-99
pubmed: 21256219
Nat Rev Immunol. 2008 Jan;8(1):34-47
pubmed: 18064051
Immunol Rev. 2015 Nov;268(1):6-24
pubmed: 26497510
J Synchrotron Radiat. 2013 Jul;20(Pt 4):660-4
pubmed: 23765312
J Immunol Methods. 2014 Jun;408:24-34
pubmed: 24810583
Protein Eng Des Sel. 2012 Dec;25(12):835-42
pubmed: 22967788
Nat Rev Immunol. 2002 Aug;2(8):580-92
pubmed: 12154377
J Phys Chem B. 1998 Apr 30;102(18):3586-616
pubmed: 24889800
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Sci Signal. 2018 Jul 24;11(540):
pubmed: 30042128
Am J Gastroenterol. 2009 Jan;104(1):102-9
pubmed: 19098857
Adv Exp Med Biol. 2017;1009:1-10
pubmed: 29218550
Nat Struct Mol Biol. 2015 Dec;22(12):953-8
pubmed: 26595420
J Appl Crystallogr. 2016 Oct 14;49(Pt 6):1861-1875
pubmed: 27980506
J Synchrotron Radiat. 2020 Sep 1;27(Pt 5):1438-1446
pubmed: 32876621
J Immunol. 2009 Jun 1;182(11):7272-9
pubmed: 19454724
PLoS One. 2015 Sep 25;10(9):e0137474
pubmed: 26406605
Curr Protein Pept Sci. 2012 Feb;13(1):55-75
pubmed: 22044150
Acta Crystallogr D Biol Crystallogr. 2015 Jan 1;71(Pt 1):67-75
pubmed: 25615861
Immunity. 2002 Mar;16(3):391-402
pubmed: 11911824
J Inflamm Res. 2016 Nov 16;9:209-219
pubmed: 27895507
J Mol Recognit. 2016 Feb;29(2):60-9
pubmed: 26762306
Biophys Rev. 2018 Apr;10(2):229-233
pubmed: 29188538
Biochemistry. 1995 Oct 17;34(41):13320-7
pubmed: 7577916
J Chem Theory Comput. 2012 Sep 11;8(9):3257-3273
pubmed: 23341755
Nat Commun. 2015 Apr 30;6:6866
pubmed: 25925696
Mol Immunol. 2013 Jul;54(3-4):403-7
pubmed: 23399386
IUCrJ. 2017 Aug 08;4(Pt 5):518-528
pubmed: 28989709
J Mol Biol. 2000 Jan 14;295(2):213-24
pubmed: 10623521
Curr Protoc Bioinformatics. 2014 Sep 08;47:5.6.1-32
pubmed: 25199792
Biochem Biophys Rep. 2017 Aug 16;12:1-4
pubmed: 28955785
Comput Struct Biotechnol J. 2013 Nov 26;8:e201308006
pubmed: 24688746
Curr Top Microbiol Immunol. 2014;382:165-99
pubmed: 25116100
Adv Exp Med Biol. 2017;1009:107-129
pubmed: 29218556
Blood. 2009 Apr 16;113(16):3716-25
pubmed: 19018092

Auteurs

Gar Kay Hui (GK)

Department of Structural and Molecular Biology, Darwin Building, University College London, London, United Kingdom.

Xin Gao (X)

Department of Structural and Molecular Biology, Darwin Building, University College London, London, United Kingdom.

Jayesh Gor (J)

Department of Structural and Molecular Biology, Darwin Building, University College London, London, United Kingdom.

Jinghua Lu (J)

Structural Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institute of Health, Rockville, Maryland, United States of America.

Peter D Sun (PD)

Structural Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institute of Health, Rockville, Maryland, United States of America.

Stephen J Perkins (SJ)

Department of Structural and Molecular Biology, Darwin Building, University College London, London, United Kingdom.

Articles similaires

Humans COVID-19 Immunoglobulin G Antibodies, Viral SARS-CoV-2
Semiconductors Photosynthesis Polymers Carbon Dioxide Bacteria
Animals Huntington Disease Mitochondria Neurons Mice
Humans Malaria, Vivax Plasmodium vivax Antibodies, Protozoan Adult

Classifications MeSH